Brief: Leqembi Included In China's Commercial Insurance Innovative Drug List
08/12/2025 23:30
Dec 8 (Reuters) - BioArctic AB BIOAb.ST: LEQEMBI INCLUDED IN CHINA'S COMMERCIAL INSURANCE INNOVATIVE DRUG LIST Source text: ID:nWkr8MMLL4 Further company coverage: [BIOAb.ST] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln